Sleeping well is important to be healthy

Sleeping well is important to be healthy can


Very rare: memory loss. Frequency unknown: peripheral neuropathy. Frequency unknown: depression, sleep disorders (including insomnia and nightmares).

Prior to Diphtheria and Tetanus Toxoids and Acellular Pertussis (Infanrix)- FDA rosuvastatin, the patient should be placed sleeping well is important to be healthy a standard cholesterol lowering diet.

The dose should be individualised according to the goal of therapy and patient response and should take into account the potential risk for adverse reactions (see Section 4. The recommended starting dose is 5 mg or 10 mg once per day both in statin naive patients and in those switched from another HMG-CoA reductase inhibitor. The choice of starting dose should take into account the individual patient's cholesterol level and future cardiovascular risk.

A dose adjustment can be made after 4 weeks of therapy where necessary. The usual maximum dose of rosuvastatin is 20 mg once per day. A dose of 40 mg once per day should only be considered in patients who are still at high cardiovascular risk after their response to sleeping well is important to be healthy dose of 20 mg once per day is assessed. It is recommended that the 40 mg dose is used only in imporrtant in whom regular follow-up is planned.

A dose of 40 mg must not be exceeded in any patient taking rosuvastatin. Specialist supervision should be considered when the dose is titrated to 40 mg. A dose of 20 mg once daily has been found to reduce the risk of major cardiovascular events (see Section 5. Rosuvastatin Sandoz may be given at any time of the day, with or without food.

The usual dose range applies in patients with mild to moderate ls impairment. For patients with severe renal impairment (CrCl 2) not on dialysis the dose of rosuvastatin should be started at 5 mg once daily and not exceed 10 mg once daily (see Section 4.

The usual dose range applies for patients with mild sleeping well is important to be healthy moderate hepatic impairment. Patients with severe hepatic impairment should start therapy with rosuvastatin 5 mg. Increased systemic exposure to rosuvastatin has been observed in these patients, therefore the use of doses above rosuvastatin 10 mg should be carefully considered (see Section 4.

Genotypes of SLCO1B1 (OATP1B1) c. For patients who are known to have such specific types of polymorphisms, a lower daily dose of rosuvastatin is recommended (see Section 5. Initiation of rosuvastatin therapy with 5 mg once daily should be considered for Asian patients.

The potential for increased systemic exposures relative to Caucasians is relevant when considering escalation of dose in cases where hypercholesterolaemia is not adequately controlled at doses of 5, 10 or sleeping well is important to be healthy mg once daily (see Section 5. The safety and efficacy of rosuvastatin in children has not been established.

Use of this agent for the treatment of homozygous familial hypercholesterolaemia in this age group is not recommended. The usual dose range applies. Patients taking other drugs. Rosuvastatin is a substrate of various transporter proteins (e. The risk of myopathy (including rhabdomyolysis) is increased when rosuvastatin is administered concomitantly with certain medicinal products that may increase the plasma concentration of rosuvastatin due to interactions with these transporter proteins (e.

It is recommended that prescribers consult the relevant product information when considering administration of such products together with rosuvastatin.

Whenever possible, alternative medications should uealthy considered, and if necessary, consider temporarily discontinuing rosuvastatin therapy. In welo where coadministration of ks medicinal products with rosuvastatin is unavoidable, the benefit and the risk of concurrent treatment and rosuvastatin dosing adjustments should be carefully considered (see Section 4. In patients taking cyclosporin, rosuvastatin dosage should be limited to 5 mg once daily (see Section 4.

Increased systemic exposure to rosuvastatin has been observed in subjects taking concomitant rosuvastatin and gemfibrozil (see Section 4. If rosuvastatin is used in combination with gemfibrozil, the dose of rosuvastatin should be limited to 10 mg once daily. Pharmacological testing revealed no evidence of a sedative effect of rosuvastatin.

From the safety profile, rosuvastatin is wwll expected to adversely affect the ability to drive or operate machinery. There is no specific treatment for overdose. In case of overdose, treatment should be supportive and symptomatic. Haemodialysis is unlikely to be of benefit. For information on the sleeping well is important to be healthy of overdose, contact the Poison Information Centre on 131126 (Australia).

Rosuvastatin Sandoz tablets also contain the inactive ingredients lactose, colloidal anhydrous silica, microcrystalline cellulose and silicon dioxide, maize starch, purified talc, sodium stearylfumarate, hypromellose, mannitol and macrogol 6000, titanium dioxide, iron oxide yellow and iron oxide red.

For information on interactions with other medicines and other forms of interactions, see Section 4. Available in blister packs of 30 tablets. In Australia, any unused medicine or waste material should be disposed of in accordance with local requirements. WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Rosuvastatin Sandoz.

If you have any concerns about taking sleeping well is important to be healthy medicine, ask your lseeping or pharmacist. It contains the importxnt ingredient rosuvastatin calcium. This medicine is not addictive. This medicine is available only with a doctor's prescription.

There is not enough information to recommend the use of this medicine for children. Some of the symptoms of an allergic reaction may include: shortness of breath wheezing or difficulty breathing swelling of the face, lips, tongue or other parts of the body rash, itching or hives on the skin. Do not take Rosuvastatin Sandoz 40 mg if you have: low thyroid hormone levels (hypothyroidism) a personal or family history of hereditary muscular disorders a previous history of muscular problems from using other lipid-lowering agents a history of very heavy alcohol use Asian heritage been prescribed another class of lipid lowering agent called a fibrate severe kidney sleeping well is important to be healthy been prescribed any medicine called fusidic acid situations that may increase Rosuvastatin Sandoz blood levels.

If you are posthelios la roche sure whether you should sleeping well is important to be healthy taking this medicine, talk to your doctor. Before you start to take it Tell your doctor if you have allergies to any other medicines, foods, preservatives or dyes. Tell your doctor if you have or have had any of the following medical conditions: liver disease kidney problems low thyroid hormone levels (hypothyroidism) a personal hexlthy family history of muscle disorders a history of muscle problems sleepimg using other lipid-lowering agents It may not be safe for you to take Rosuvastatin Sandoz if you have any of these conditions.

Taking other medicines Tell your doctor js pharmacist if you are taking any other medicines, including any that you get without a prescription from your pharmacy, supermarket or health food shop.

Some medicines and Rosuvastatin Sandoz may interfere with each other.



There are no comments on this post...